Fénichel P, Brucker-Davis F
Inserm U895, service d'endocrinologie et médecine de la reproduction, hôpital de l'Archet I, CHU de Nice, BP 3079, 06202 Nice cedex 03, France.
Gynecol Obstet Fertil. 2008 Oct;36(10):969-77. doi: 10.1016/j.gyobfe.2008.05.006. Epub 2008 Sep 19.
Human epidemiological studies and experimental animal data strongly suggest that xenobiotics with estrogenic activity may participate in to the increasing incidence of breast cancer, the most frequent cancer all around the world. Several reports have since 15 years reported positive correlations between blood or peritumoral adipose tissue levels of persistent organic compounds including organochloride pesticides and breast cancer risk. Moreover, fetal or perinatal exposition to low doses of such endocrine disruptors induce premalignant or malignant transformation of adult mammary gland in rodents. However, this environmental endocrine disrupter hypothesis still needs to be demonstrated. Further human studies are needed which will consider the exposition window, the association of several xenoestrogens, the molecular mechanisms involved and the possible individual genetic susceptibility in order to identify pertinent biomarkers and to define acceptable environmental concentration levels for agricultural or industrial chemical new products to be used.
人类流行病学研究和实验动物数据有力地表明,具有雌激素活性的外源性物质可能与全球最常见的癌症——乳腺癌发病率的上升有关。自15年前以来,已有几份报告指出,包括有机氯农药在内的持久性有机化合物的血液或肿瘤周围脂肪组织水平与乳腺癌风险之间存在正相关。此外,胎儿或围产期接触低剂量的此类内分泌干扰物会诱导啮齿动物成年乳腺发生癌前或恶性转化。然而,这种环境内分泌干扰物假说仍有待证实。需要进一步开展人类研究,考虑暴露窗口期、多种外源性雌激素的关联、涉及的分子机制以及可能的个体遗传易感性,以便识别相关生物标志物,并确定农业或工业用新化学产品可接受的环境浓度水平。